News list for "Bio"

Wantai Bio: Nine-valent HPV vaccine approved for marketing

On June 4th, Wantai Biotechnology announced that the nine-valent human papillomavirus vaccine (Escherichia coli) (trade name: Xinkening 9) declared by Xiamen Wantai Canghai Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, has been approved for marketing. The vaccine is suitable for women aged 9-45. Among them, 9-17 years old can use the two-dose vaccination procedure, and 18-45 years old can use the three-dose vaccination procedure. Previously, only one nine-valent HPV vaccine ...

clock
2025-06-04 07:32:43
Symbiotics Launches "Relay" for Cross-Chain Security Pledging

According to CoinDesk, the staking protocol Symbiotic has launched the Relay Software Development Kit (SDK), which allows developers to stake assets on Ethereum and verify the staking status on any blockchain. Relay is a generic version of Symbiotic's re-staking technology that supports building a security coordination layer for cross-chain decentralized applications. Symbiotic co-founder Algys Ievlev said that the technology solves the long-standing security verification challenge faced by deve...

clock
2025-06-03 14:33:58
Symbiotic推出“Relay”以实现跨链安全质押

据CoinDesk报道,质押协议Symbiotic推出Relay软件开发工具包(SDK),该技术允许开发者在以太坊质押资产并在任意区块链验证质押状态。Relay作为Symbiotic再质押技术的通用版本,支持构建跨链去中心化应用的安全协调层。 Symbiotic联合创始人Algys Ievlev表示,该技术解决了多链协议开发者长期面临的安全验证难题,无需依赖可信...

clock
2025-06-03 14:33:58
Class A shares pet economic concept continued to rise, Loos shares 30cm limit, reliable shares, Tianyuan pets, Chuangyuan shares, Yiyi shares, Yuanfei pets and other multi-share sealing board, Petty shares, Jieya shares, Rip biological and other shares rose more than 10%.

Class A shares pet economic concept continued to rise, Loos shares 30cm limit, reliable shares, Tianyuan pets, Chuangyuan shares, Yiyi shares, Yuanfei pets and other multi-share sealing board, Petty shares, Jieya shares, Rip biological and other shares rose more than 10%.

clock
2025-05-20 02:57:31
Listed company Quantum BioPharma is worth $1 million in cryptocurrency

Public company Quantum BioPharma announced that it has purchased an additional $1 million worth of bitcoin and other cryptocurrencies as part of its strategic move, following board approval. This brings the total amount of bitcoin and other cryptocurrencies purchased by the company to $4.50 million. The company is now ready to accept financing in cryptocurrencies and execute other types of cryptocurrency transactions.

clock
2025-05-19 12:48:03
上市公司Quantum BioPharma价值增持100万美元的加密货币

上市公司Quantum BioPharma宣布,在获得董事会批准后,公司已额外购买了价值100万美元的比特币及其他加密货币,作为其战略举措的一部分。这使得公司购买的比特币及其他加密货币的总金额达到450万美元。公司现已做好准备,可以接受以加密货币进行的融资,并执行其他类型的加密货币交易。

clock
2025-05-19 12:48:03
A Kenyan court has ordered Sam Altman's World project to delete biometric user data

According to Decrypt, Kenya's High Court ruled that Sam Altman's World project (formerly Worldcoin) illegally collected citizens' biometric data, requiring it to delete all iris information collected in Kenya within seven days and permanently stop inducing data collection with cryptocurrency rewards. The judge found that the project had not been approved by the Office of Data Protection Officer (ODPC) and that the "consent" obtained by issuing WLD tokens was invalid, violating the country's cons...

clock
2025-05-06 09:25:37
ether.fi launched a $40 million venture capital fund, the first investment projects are Resolv, Rise Chain, Symbiotic

ether.fi announced the launch of ether.fi Ventures Fund I, a $40 million venture capital fund designed to support intrepid entrepreneurs who are redefining what's possible in the industry. In addition, the fund has now revealed its first investment projects, namely Resolv, Rise Chain, and Symbiotic.

clock
2025-04-29 00:28:43
ether.fi 推出4000万美元的风投基金,首批投资项目为Resolv、Rise Chain、Symbiotic

ether.fi 宣布已推出一支 4000 万美元的风险投资基金 ether.fi Ventures Fund I,旨在支持那些重新定义行业可能性的无畏创业者。 此外,该基金现已披露首批投资项目,分别为 Resolv、Rise Chain、Symbiotic。

clock
2025-04-29 00:28:43
Symbiotic completes $29 million Series A financing

Cryptocurrency staking protocol Symbiotic completed a $29 million Series A financing round led by Pantera Capital and Coinbase Ventures, with the participation of more than 100 institutions and angel investors including Aave, Polygon and StarkWare. The financing will be used to launch the "Common Staking Framework", a blockchain security coordination layer. The framework allows any combination of cryptocurrencies (including L1/L2 chain assets) to participate in network verification. It has been ...

clock
2025-04-23 13:06:03
再质押协议Symbiotic完成2900万美元A轮融资

加密货币质押协议Symbiotic完成2900万美元A轮融资,由Pantera Capital和Coinbase Ventures领投,Aave、Polygon及StarkWare等逾100家机构与天使投资人参与。融资将用于推出区块链安全协调层“通用质押框架”。该框架允许任意组合的加密货币(包括L1/L2链资产)参与网络验证,目前已获Hyperlane等14个网络采用,预计还将接入20个生态项目。

clock
2025-04-23 13:06:03
Hong Kong stocks closed, the Hang Seng Index closed up 0.23%, the Hang Seng Technology Index closed down 0.67%, Yingen Biological (09606.HK) closed up 116.70% on the first day of listing, and SMIC International (00981.HK) closed down 4.53%.

Hong Kong stocks closed, the Hang Seng Index closed up 0.23%, the Hang Seng Technology Index closed down 0.67%, Yingen Biological (09606.HK) closed up 116.70% on the first day of listing, and SMIC International (00981.HK) closed down 4.53%.

clock
2025-04-15 08:08:47
Class A shares of agricultural stocks continued to explode in the afternoon, Qiule Seed Industry, Huaxi Shares, Zhejiang Danong, Hualu Bio, Chenguang Bio, Snow Banyan Bio, Shennong Seed Industry, Fengle Seed Industry, Xinsai Shares, Beidahuang, Zhongxing Bacteria Industry and other more than 20 stocks sealed daily limit.

Class A shares of agricultural stocks continued to explode in the afternoon, Qiule Seed Industry, Huaxi Shares, Zhejiang Danong, Hualu Bio, Chenguang Bio, Snow Banyan Bio, Shennong Seed Industry, Fengle Seed Industry, Xinsai Shares, Beidahuang, Zhongxing Bacteria Industry and other more than 20 stocks sealed daily limit.

clock
2025-04-08 05:06:52
Nasdaq-listed company BioNexus Gene Lab announces adoption of Ethereum financial reserve strategy

According to Globenewswire, BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to technological innovation and healthcare, announced that its board of directors has officially approved the company's new Ethereum-focused financial strategy. This decision marks BGLC becoming the first Nasdaq-listed company to prioritize Ethereum as an exclusive strategic financial asset, and follows the recent inclusion of Ethereum in the US "...

clock
2025-03-06 02:17:44
纳斯达克上市公司BioNexus Gene Lab宣布采用以太坊财务储备战略

据Globenewswire报道,致力于技术创新与医疗保健的科技公司BioNexus Gene Lab Corp.(纳斯达克股票代码:BGLC)宣布,其董事会已正式批准公司新的以太坊专注型财务战略。此决策标志着BGLC成为首家将以太坊作为战略财务资产独家优先考虑的纳斯达克上市公司,并与近期以太坊被纳入美国“...

clock
2025-03-06 02:17:44